A 76-year-old man with history of endovascular repair of an infrarenal abdominal aortic aneurysm and right hypogastric artery embolization was found to have a persistent type II endoleak 2 years after his initial repair. Sac expansion by 1.6 cm during the following year prompted intervention by direct sac injection. Further sac expansion by 1 cm during 3 months elevated concern for occult proximal perigraft flow (type IA endoleak). We subsequently performed Aptus EndoAnchor (Aptus Endosystems, Sunnyvale, Calif) placement, with completion angiography demonstrating improved graft apposition. Interval imaging, however, demonstrated further sac expansion, and computed tomography (CT)-guided translumbar direct sac injection was performed (*A*). A total of 1 g of *n-*butyl cyanoacrylate was used. Completion CT showed glue cast filling of the endoleak sac with extension into the inferior mesenteric artery and secondary branches (*B*). After the procedure, the patient developed abdominal distention with focal peritonitis and was taken to the operating room for exploratory laparotomy. He was found to have a completely ischemic sigmoid colon requiring resection. Follow-up CT angiography demonstrated resolution of endoleak and decrease in the sac size by 0.6 cm (*C*). The patient\'s consent has been obtained for the publication of this case report.

Discussion {#sec1}
==========

Nearly 90% of all abdominal aortic aneurysm repairs in the United States are now performed by endovascular approach.[@bib1] Type II endoleaks are the most common complication after endovascular aneurysm repair, but indications for intervention are increasingly being questioned.[@bib2] Sac expansion is consistent with persistent pressurization, increased risk of graft malfunction, and possible rupture in the absence of more sensitive monitoring strategies.[@bib3] Direct sac injection provides a highly successful treatment approach; however, rare complications related to nontarget embolization, including ischemic colitis, have been reported.[@bib4] Even with the use of fast polymerizing agents like *n*-butyl cyanoacrylate during direct sac injection, collateral embolization can occur.[@bib5] Outflow vessel control with transarterial coil embolization before direct sac puncture may prevent this complication and should be considered before any intervention.
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